🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EDAP TMS announces a record 2022 preliminary unaudited revenue of €55.1 million, a 25.1% increase vs 2021. Read more about the growing momentum and interest in Focal One #HIFU here : investor.edap-tms.com/news-releases/… #FocalOne #Innovation #medicaldevice

Fancy a live demonstration of the #ExactVu Micro-Ultrasound? EDAP TMS and Exact Imaging teams will be happy to guide you through the revolutionary 29 MHz imaging system. Click here to book your demo with one of our experts at #EAU23: form.jotform.com/221433878859370

Focal therapy is emerging as an effective alternative to active surveillance and radical treatment. #FocalOne offers all the benefits for urologists Discover all #FocalOne benefits on our booth #B30 at #EAU23 to and book your demo here: form.jotform.com/221433878859370

Are you considering a #FocalTherapy program in your hospital / clinic? EDAP TMS offers and end to end prostate cancer solution, from imaging to treatment. Come over to our booth next week in #Milan to discuss it with our specialists #ExactVU #FocalOne #EAU23

A great program is underway for #EAU23 in Milan. Don't miss out on the #ExactVu Hands-on sessions on MRI Fusion biopsy by Giovanni Lughezzani & Urological Ultrasound by Hannes Cash

Thank you to the European Association of #Urology and all the attendees of this 38th edition in #Milan for making this an EAU to remember. We look forward to next year : rendez-vous in #Paris ! #FocalOne #ExactVU #EAU23

We are proud to share the final Consolidated results of the HIFI study presented at #EAU23 by Pr Pascal Rischmann. Read all about it here : investor.edap-tms.com/news-releases/… #FocalOne #ProstateCancer

Pr Gil Dubernard will unveil groundbreaking results of Endo HIFU R1 study at #WCE on May 4th. Join the State-of-the-Art Surgery session to learn about #FocalOne robotic #HIFU for managing #RectalEndometriosis & gain insights from phase I French multicentric study with 60 patients

Ne manquez pas l'émission Grand Angle du 12 mai sur France Inter où le Pr. Gil Dubernard explique que "Le traitement par ultrasons pourrait bouleverser la vie des femmes atteintes d'endométriose". Écoutez ici : radiofrance.fr/franceinter/po… #endometriose #HIFU #innovation

Join Prof. Giovanni Lughezzani at #UAAEUSC2023 for live demos of #MicroUltrasound's latest urological #imaging innovation. Learn about real-time targeted biopsies for better #ProstateCancer diagnosis and the groundbreaking #ExactVu Micro-ultrasound system. uaa2023.org/workshop-progr…

Don't Miss Out! Join us for a symposium at the UAA-EUSC congress with Dr.Giovanni Lughezzani. Discover a new approach to prostate cancer diagnosis with ExactVu™ micro-ultrasound tech. #UAAEUSC2023 #Symposium #ProstateCancer #Innovation #MicroUltrasound #ExactVu

Congratulations to Dr Hannes Cash, NiklasHarland, Amir Lebastchi, MD & Yamini Nagaraj for an outstanding presentation and an engaging discussion on the topic of #MicroUltrasound with #ExactVu and Focal therapy with #FocalOne at #DGU2023 in Leipzig

📸 Live from UAA EUSC Congress in Dubai! Our booth has been buzzing with activity, and these snapshots capture the engagement we've experienced so far. We're here for two more days, so if you haven't had a chance to visit us yet, there's still time. See you soon! #UAAEUSC2023

Congratulations to Professor Gil Dubernard (HCL Lyon, FR) for his presentation of the excellent results of the ENDO HIFU R1 safety study, evaluating the treatment of posterior deep #Endometriosis using Focal One robotic #HIFU, at the ESGE congress in Brussels.

Pour la 2ème année, nous sommes aux côtés d’@ENDOmind France dans la lutte contre l'#endométriose en tant que sponsor Silver de l'#EndoRun 2023. Nos collaborateurs et partenaires, HCL & LabTAU, relèvent le défi avec déjà 53 inscrits! Rejoignez-nous sur endorun.fr

Congratulations to Pr Gil Dubernard (HCL, France) for chairing the session "HIFU in Functional Gynecological Diseases" and for his great presentation of the results of the Phase 2 Multicentric Safety Study including 60 patients. #AAGL2023 #Endometriosis #Medtech #WomensHealth

Did you know? Focal One is the only fully robotic HIFU platform with 5 motions, redefining precision in prostate care. Urologists gain unprecedented control, while patients experience enhanced outcomes. #Cancer |#RoboticSurgery |#Urology |#ProstateCancer | #MedTech

Precision Unveiled: Focal One's Dynamic Focusing Technology Focal One Robotic HIFU integrates a unique dynamic focusing technology, ensuring conformational, precise, and swift ablation in prostate cancer treatment #Cancer |#RoboticSurgery |#Urology |#ProstateCancer | #MedTech